Vision Eye Seriously in Play

July was an action packed month for sleepy Vision Eye Institute (VEI). ASX-listed Pulse Healthcare launched an unlikely looking all scrip offer for Vision at the start of the month. Nominally the offer values Vision at $0.88 a share, but it's all payable in Pulse scrip. Optimistically priced Pulse scrip doesn't look particularly attractive in exchange for our cheap looking Vision shares. Bigger news arrived on Friday. Primary Healthcare - Vision's largest shareholder - announced it had sold its 20% stake in Vision to Chinese company Jangho Group. The price was $0.94, a significant premium to the then market price. And Jangho is a $3bn company listed on the Shanghai stock exchange. I doubt they are looking for a passive 20% shareholding. They probably want the lot, and are presumably prepared to pay at least $0.94 for it. Lot's of questions remain - most significantly why Primary would sell if there is a takeover off coming - but it's safe to say August is going to be another interesting month for Vision shareholders. Forager funds own VEI.


MORE ON



Founder & Chief Investment Officer
Forager

Steve began Forager Funds in 2009, and now manages approximately $470m across two funds. Offering a listed Australian Shares Fund (FOR) and an unlisted International Shares Fund, Steve focuses on long-term investing in undervalued companies.

I would like to

Only to be used for sending genuine email enquiries to the Contributor. Livewire Markets Pty Ltd reserves its right to take any legal or other appropriate action in relation to misuse of this service.

Personal Information Collection Statement
Your personal information will be passed to the Contributor and/or its authorised service provider to assist the Contributor to contact you about your investment enquiry. They are required not to use your information for any other purpose. Our privacy policy explains how we store personal information and how you may access, correct or complain about the handling of personal information.